DAVID ROWLEY to Recombinant Fusion Proteins
This is a "connection" page, showing publications DAVID ROWLEY has written about Recombinant Fusion Proteins.
Connection Strength
0.032
-
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther. 2013 Aug; 21(8):1611-20.
Score: 0.021
-
Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205.
Score: 0.011